This inventor holds 2 USPTO granted patents and 28 published patent applications. Top assignee: Baylor College of Medicine. Active years: 1985-1987.
Company Filing History:
Years Active: 1985-1987
Title: Innovations of Raymond Y Chan
Introduction
Raymond Y Chan is a notable inventor based in San Diego, CA. He has made significant contributions to the field of ophthalmology, particularly in the development of mitotic inhibitors aimed at preventing posterior lens capsule opacification. With a total of 2 patents, his work has the potential to improve outcomes for patients undergoing cataract surgery.
Latest Patents
One of his latest patents focuses on mitotic inhibitors that prevent posterior lens capsule opacification after extracapsular extraction. The disclosed mitotic inhibitors comprise osmotically balanced solutions containing either methotrexate or retinoic acid, or both, administered in at least the minimal effective dosage at the end of one lens epithelial cell cycle. These inhibitors are instilled in the anterior chamber of the eye, preferably immediately after the lens has been removed. This innovative approach aims to enhance the surgical experience and recovery for patients.
Career Highlights
Raymond Y Chan is affiliated with the Baylor College of Medicine, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving medical procedures and patient care through innovative solutions.
Collaborations
Raymond collaborates with various professionals in his field, including his coworker Jared M Emery. Their combined expertise contributes to the ongoing research and development of effective treatments in ophthalmology.
Conclusion
Raymond Y Chan's contributions to the field of ophthalmology through his innovative patents demonstrate his dedication to improving patient outcomes. His work with mitotic inhibitors is a testament to the impact of research and innovation in medicine.